Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free ELMD Stock Alerts

Electromed (ELMD) Financials

Electromed logo
$45.82 +1.88 (+4.28%)
Closing price 07/9/2026 04:00 PM Eastern
Extended Trading
$45.93 +0.11 (+0.24%)
As of 07/9/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Electromed

Annual Income Statements for Electromed

This table shows Electromed's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 1.09 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54
Consolidated Net Income / (Loss)		 1.09 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54
Net Income / (Loss) Continuing Operations		 1.09 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54
Total Pre-Tax Income 		1.22 3.04 3.52 2.73 2.92 5.24 3.17 3.00 4.09 7.04 10
Total Operating Income		 1.31 3.11 3.57 2.71 2.83 5.12 3.14 2.97 4.01 6.58 9.66
Total Gross Profit		 14 18 21 22 24 25 27 31 37 42 50
Total Revenue		 19 23 26 28 31 32 36 42 48 55 64
Operating Revenue		 19 23 26 28 31 32 36 42 48 55 64
Total Cost of Revenue		 5.81 5.12 5.29 6.53 7.45 7.27 8.45 10 12 13 14
Operating Cost of Revenue		 5.81 5.12 5.29 6.53 7.45 7.27 8.45 10 12 13 14
Total Operating Expenses		 12 15 17 19 21 20 24 28 33 35 40
Selling, General & Admin Expense		 12 14 16 19 20 20 22 27 32 34 39
Research & Development Expense		 0.32 0.38 0.60 0.25 0.58 1.05 1.72 1.36 0.92 0.66 1.00
Total Other Income / (Expense), net		 -0.09 -0.07 -0.05 0.02 0.09 0.12 0.03 0.03 0.08 0.46 0.62
Interest & Investment Income		 - - - - - - - - - 0.46 0.62
Income Tax Expense		 0.13 0.83 1.29 0.90 0.94 1.08 0.81 0.69 0.92 1.89 2.75
Basic Earnings per Share		 $0.13 $0.27 $0.27 $0.22 $0.24 $0.50 $0.28 $0.27 $0.37 $0.60 $0.89
Weighted Average Basic Shares Outstanding		 8.12M 8.14M 8.17M 8.21M 8.31M 8.40M 8.57M 8.47M 8.46M 8.56M 8.45M
Diluted Earnings per Share		 $0.13 $0.27 $0.26 $0.21 $0.23 $0.47 $0.27 $0.26 $0.36 $0.58 $0.85
Weighted Average Diluted Shares Outstanding		 8.15M 8.25M 8.46M 8.62M 8.63M 8.83M 8.91M 8.77M 8.70M 8.86M 8.91M
Weighted Average Basic & Diluted Shares Outstanding		 8.16M 8.22M 8.26M 8.33M 8.44M 8.57M 8.59M 8.48M 8.56M 8.64M 8.35M

Quarterly Income Statements for Electromed

This table shows Electromed's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 0.16 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00
Consolidated Net Income / (Loss)		 0.16 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00
Net Income / (Loss) Continuing Operations		 0.16 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00
Total Pre-Tax Income 		0.22 2.36 1.96 2.50 2.13 2.69 2.28 3.18 2.80 3.73 3.87
Total Operating Income		 0.14 2.26 1.84 2.34 1.94 2.54 2.14 3.04 2.67 3.62 3.77
Total Gross Profit		 9.50 11 10 11 11 13 12 14 13 15 15
Total Revenue		 12 14 14 15 15 16 16 17 17 19 19
Operating Revenue		 12 14 14 15 15 16 16 17 17 19 19
Total Cost of Revenue		 2.83 3.14 3.49 3.53 3.18 3.63 3.46 3.77 3.69 4.08 3.93
Operating Cost of Revenue		 2.83 3.14 3.49 3.53 3.18 3.63 3.46 3.77 3.69 4.08 3.93
Total Operating Expenses		 9.36 8.28 8.54 8.97 9.55 10 10 11 11 11 11
Selling, General & Admin Expense		 9.15 8.18 8.37 8.79 9.39 9.83 9.81 10 10 11 11
Research & Development Expense		 0.21 0.11 0.17 0.18 0.17 0.25 0.28 0.30 0.24 0.38 0.36
Total Other Income / (Expense), net		 0.08 0.10 0.12 0.16 0.20 0.15 0.14 0.14 0.13 0.11 0.10
Interest & Investment Income		 - - 0.12 - 0.20 0.15 0.14 - 0.13 0.11 0.10
Income Tax Expense		 0.06 0.69 0.47 0.67 0.66 0.73 0.39 0.97 0.67 0.97 0.86
Basic Earnings per Share		 $0.02 $0.20 $0.17 $0.21 $0.17 $0.23 $0.22 $0.27 $0.26 $0.33 $0.37
Weighted Average Basic Shares Outstanding		 8.54M 8.55M 8.57M 8.56M 8.56M 8.42M 8.50M 8.45M 8.32M 8.27M 8.21M
Diluted Earnings per Share		 $0.02 $0.19 $0.17 $0.20 $0.16 $0.22 $0.21 $0.26 $0.25 $0.32 $0.35
Weighted Average Diluted Shares Outstanding		 8.78M 8.80M 8.89M 8.86M 8.98M 8.95M 8.97M 8.91M 8.68M 8.69M 8.65M
Weighted Average Basic & Diluted Shares Outstanding		 8.58M 8.61M 8.66M 8.64M 8.46M 8.56M 8.39M 8.35M 8.34M 8.28M 8.28M

Annual Cash Flow Statements for Electromed

This table details how cash moves in and out of Electromed's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 2.10 1.53 0.45 1.88 0.35 2.67 1.41 -3.74 -0.78 8.71 -0.79
Net Cash From Operating Activities		 2.78 2.17 1.19 2.44 2.59 4.20 3.08 -0.69 1.32 9.07 11
Net Cash From Continuing Operating Activities		 2.78 2.17 1.19 2.44 2.59 4.20 3.08 -0.69 1.32 9.07 11
Net Income / (Loss) Continuing Operations		 1.09 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54
Consolidated Net Income / (Loss)		 1.09 2.21 2.23 1.83 1.98 4.16 2.36 2.31 3.17 5.15 7.54
Depreciation Expense		 0.61 0.62 0.64 0.68 0.80 0.62 0.48 0.50 0.55 0.79 1.04
Amortization Expense		 0.14 0.14 0.13 0.12 0.12 0.12 0.13 0.13 0.06 0.05 0.13
Non-Cash Adjustments To Reconcile Net Income		 0.41 0.28 0.62 0.91 0.72 1.00 2.60 1.35 0.78 1.46 2.95
Changes in Operating Assets and Liabilities, net		 0.52 -1.08 -2.42 -1.10 -1.04 -1.70 -2.50 -4.97 -3.25 1.62 -0.27
Net Cash From Investing Activities		 -0.62 -0.58 -0.69 -0.57 -1.39 -0.98 -0.45 -1.53 -1.72 -0.40 -0.31
Net Cash From Continuing Investing Activities		 -0.62 -0.58 -0.69 -0.57 -1.39 -0.98 -0.45 -1.53 -1.72 -0.40 -0.31
Purchase of Property, Plant & Equipment		 -0.52 -0.53 -0.62 -0.53 -1.33 -0.84 -0.29 -1.43 -1.65 -0.29 -0.26
Acquisitions		 -0.10 -0.04 -0.07 -0.05 -0.06 -0.13 -0.16 -0.10 -0.07 -0.11 -0.04
Net Cash From Financing Activities		 -0.06 -0.06 -0.05 0.01 -0.85 -0.55 -1.22 -1.53 -0.38 0.04 -12
Net Cash From Continuing Financing Activities		 -0.06 -0.06 -0.05 0.01 -0.85 -0.55 -1.22 -1.53 -0.38 0.04 -12
Repurchase of Common Equity		 - - - - - 0.00 -1.12 -1.45 -0.15 -0.28 -10
Other Financing Activities, net		 - - - 0.06 0.25 -0.63 -0.14 -0.08 -0.31 0.31 -1.88
Cash Income Taxes Paid		 0.00 1.49 1.09 1.02 1.31 1.76 0.53 1.42 0.68 2.51 3.74

Quarterly Cash Flow Statements for Electromed

This table details how cash moves in and out of Electromed's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.35 3.41 1.28 4.37 -2.22 2.37 -1.00 0.05 -1.17 -0.32 3.19
Net Cash From Operating Activities		 -0.24 3.47 1.35 4.49 2.31 3.15 2.07 3.86 0.17 3.03 3.48
Net Cash From Continuing Operating Activities		 -0.24 3.47 1.35 4.49 2.31 3.15 2.07 3.86 0.17 3.03 3.48
Net Income / (Loss) Continuing Operations		 0.16 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00
Consolidated Net Income / (Loss)		 0.16 1.67 1.49 1.83 1.47 1.97 1.89 2.20 2.14 2.76 3.00
Depreciation Expense		 0.20 0.20 0.20 0.20 0.20 0.21 0.25 0.38 0.21 0.21 0.22
Amortization Expense		 0.01 0.01 0.01 0.02 0.02 0.06 0.03 0.02 0.05 0.05 0.07
Non-Cash Adjustments To Reconcile Net Income		 -0.86 1.35 0.60 1.27 0.66 2.19 0.63 0.95 0.32 0.67 0.96
Changes in Operating Assets and Liabilities, net		 0.25 0.24 -0.95 1.18 -0.05 -1.27 -0.73 0.31 -2.55 -0.67 -0.78
Net Cash From Investing Activities		 -0.13 -0.09 -0.13 -0.05 -0.06 -0.24 0.15 -0.16 -0.27 -0.66 -0.15
Net Cash From Continuing Investing Activities		 -0.13 -0.09 -0.13 -0.05 -0.06 -0.24 0.15 -0.16 -0.27 -0.66 -0.15
Purchase of Property, Plant & Equipment		 -0.11 -0.07 -0.09 -0.02 -0.04 -0.23 0.15 -0.15 -0.25 -0.63 -0.15
Acquisitions		 -0.02 -0.02 -0.04 -0.02 -0.02 -0.00 -0.01 -0.01 -0.02 -0.02 -0.01
Net Cash From Financing Activities		 0.03 0.03 0.06 -0.08 -4.47 -0.54 -3.22 -3.65 -1.08 -2.69 -0.13
Net Cash From Continuing Financing Activities		 0.03 0.03 0.06 -0.08 -4.47 -0.54 -3.22 -3.65 -1.08 -2.69 -0.13
Repurchase of Common Equity		 0.00 - - -0.28 -4.54 - -1.80 -3.67 -1.00 -2.76 -0.15
Other Financing Activities, net		 0.00 - 0.11 - 0.07 -0.81 -1.42 0.02 -0.07 0.07 0.02
Cash Income Taxes Paid		 0.25 0.58 0.97 0.71 0.75 1.43 0.81 0.76 0.47 0.38 1.26

Annual Balance Sheets for Electromed

This table presents Electromed's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets		 17 21 23 8.93 29 33 37 41 46 52 54
Total Current Assets		 13 16 18 8.23 25 28 32 35 38 44 45
Cash & Equivalents		 3.60 5.12 5.57 7.46 7.81 10 12 8.15 7.37 16 15
Accounts Receivable		 6.52 7.61 9.95 - 13 13 17 21 24 23 25
Inventories, net		 2.07 2.48 2.56 - 2.62 3.09 2.11 3.18 4.22 3.71 3.30
Prepaid Expenses		 0.40 0.42 0.39 - 0.35 0.35 0.28 1.87 1.58 0.33 0.39
Current Deferred & Refundable Income Taxes		 - 0.19 - - 0.00 0.26 - - - 0.00 0.41
Other Current Assets		 - - - 0.78 1.00 0.90 0.39 0.29 0.49 0.72 1.04
Plant, Property, & Equipment, net		 3.64 3.38 3.30 0.00 3.60 3.79 3.61 4.57 5.67 5.17 4.71
Total Noncurrent Assets		 1.18 1.37 1.28 0.69 1.26 1.43 1.80 2.26 2.35 2.90 4.01
Intangible Assets		 1.00 0.90 0.72 0.65 0.58 0.60 0.66 0.60 0.61 0.66 0.37
Noncurrent Deferred & Refundable Income Taxes		 - 0.34 0.46 - 0.63 0.76 1.05 1.54 1.58 2.15 2.46
Other Noncurrent Operating Assets		 0.18 0.13 0.10 0.05 0.05 0.08 0.09 0.12 0.16 0.09 1.17
Total Liabilities & Shareholders' Equity		 17 21 23 10 29 33 37 41 46 52 54
Total Liabilities		 3.48 4.22 3.99 0.81 3.67 3.00 4.69 7.19 8.14 7.69 11
Total Current Liabilities		 2.28 3.07 2.90 0.79 3.65 2.99 4.64 7.15 8.05 7.68 10
Accounts Payable		 0.54 0.59 0.66 - 0.59 0.56 0.69 1.26 1.37 1.01 2.67
Accrued Expenses		 0.66 0.66 0.64 0.76 0.81 0.74 0.94 1.26 1.38 2.50 2.72
Current Employee Benefit Liabilities		 0.70 1.49 0.95 - 1.40 1.40 2.47 2.74 3.02 3.89 5.08
Total Noncurrent Liabilities		 1.20 1.15 1.10 0.01 0.01 0.01 0.05 0.04 0.09 0.01 0.13
Other Noncurrent Operating Liabilities		 - - - - 0.01 - - - - 0.01 0.13
Total Equity & Noncontrolling Interests		 14 16 19 9.52 26 30 32 34 38 45 43
Total Preferred & Common Equity		 14 16 19 9.52 26 30 32 34 38 45 43
Total Common Equity		 14 16 19 9.52 26 30 32 34 38 45 43
Common Stock		 13 14 14 - 16 17 17 18 19 21 22
Retained Earnings		 0.51 2.73 4.96 9.52 9.52 14 15 16 19 24 21

Quarterly Balance Sheets for Electromed

This table presents Electromed's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 44 47 49 49 52 52 54 55 59
Total Current Assets		 36 39 41 41 44 44 45 46 50
Cash & Equivalents		 7.02 10 12 14 16 15 14 14 17
Accounts Receivable		 23 23 24 22 23 23 25 26 28
Inventories, net		 4.48 4.76 4.18 3.43 3.08 2.97 3.77 3.46 3.30
Prepaid Expenses		 0.69 0.51 0.59 0.59 0.59 0.49 0.54 0.91 0.60
Current Deferred & Refundable Income Taxes		 - - 0.29 - 0.51 0.93 0.21 0.00 0.02
Other Current Assets		 0.54 0.57 0.64 0.75 1.00 1.12 1.17 1.15 1.09
Plant, Property, & Equipment, net		 5.53 5.38 5.28 5.00 5.22 4.81 4.98 5.22 5.21
Total Noncurrent Assets		 2.34 2.32 2.30 2.90 2.87 3.44 4.08 4.13 4.04
Intangible Assets		 0.61 0.62 0.65 0.66 0.61 0.59 0.39 0.39 0.35
Noncurrent Deferred & Refundable Income Taxes		 1.58 1.58 1.54 2.15 2.15 2.15 2.46 2.46 2.46
Other Noncurrent Operating Assets		 0.14 0.13 0.11 0.09 0.11 0.70 1.23 1.28 1.22
Total Liabilities & Shareholders' Equity		 44 47 49 49 52 52 54 55 59
Total Liabilities		 5.84 6.62 6.36 7.43 8.67 8.51 8.87 9.47 10
Total Current Liabilities		 5.78 6.57 6.33 7.42 8.67 8.51 8.76 9.38 10
Accounts Payable		 1.06 1.04 0.79 1.78 1.51 1.88 3.14 2.32 2.60
Accrued Expenses		 1.42 1.48 1.53 1.64 1.60 2.66 2.89 2.96 3.10
Current Employee Benefit Liabilities		 1.84 2.81 2.99 2.15 3.62 3.97 2.73 3.71 4.53
Total Noncurrent Liabilities		 0.07 0.05 0.03 0.01 0.00 0.00 0.11 0.10 0.08
Other Noncurrent Operating Liabilities		 - - - - - 0.00 0.11 0.10 0.08
Total Equity & Noncontrolling Interests		 38 40 43 41 44 44 45 45 49
Total Preferred & Common Equity		 38 40 43 41 44 44 45 45 49
Total Common Equity		 38 40 43 41 44 44 45 45 49
Common Stock		 19 20 20 21 21 21 22 23 24
Retained Earnings		 19 21 22 21 23 23 22 22 25

Annual Metrics And Ratios for Electromed

This table displays calculated financial ratios and metrics derived from Electromed's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
DEI Shares Outstanding		 8,133,857.00 8,187,112.00 8,230,167.00 8,288,659.00 8,408,351.00 8,483,785.00 8,637,420.00 8,513,035.00 8,561,100.00 - 8,386,115.00
DEI Adjusted Shares Outstanding		 8,133,857.00 8,187,112.00 8,230,167.00 8,288,659.00 8,408,351.00 8,483,785.00 8,637,420.00 8,513,035.00 8,561,100.00 - 8,386,115.00
DEI Earnings Per Adjusted Shares Outstanding		 0.13 0.27 0.27 0.22 0.24 0.49 0.27 0.27 0.37 - 0.90
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 25.31% 18.46% 12.48% 9.46% 10.57% 3.74% 10.12% 16.51% 15.38% 13.83% 16.97%
EBITDA Growth		 7,742.81% 87.16% 12.20% -19.11% 7.07% 55.96% -36.00% -4.00% 28.36% 60.61% 45.94%
EBIT Growth		 276.91% 137.32% 14.80% -24.01% 4.33% 80.87% -38.65% -5.35% 34.86% 64.20% 46.79%
NOPAT Growth		 325.49% 93.43% 0.00% -19.60% 5.55% 111.84% -42.39% -2.40% 35.86% 55.11% 46.97%
Net Income Growth		 184.78% 102.52% 0.77% -17.87% 8.15% 110.12% -43.23% -2.41% 37.35% 62.67% 46.35%
EPS Growth		 181.25% 107.69% -3.70% -19.23% 9.52% 104.35% -42.55% -3.70% 38.46% 61.11% 46.55%
Operating Cash Flow Growth		 34.54% -22.09% -45.03% 105.03% 6.05% 62.02% -26.67% -122.29% 291.69% 589.51% 25.65%
Free Cash Flow Firm Growth		 18.46% -33.14% -96.64% 33,170.19% -197.32% 114.15% -25.65% -298.05% 61.98% 653.42% 13.21%
Invested Capital Growth		 -7.50% 7.36% 17.81% -95.15% 2,427.71% 10.56% 3.67% 26.63% 16.58% -6.27% -1.91%
Revenue Q/Q Growth		 3.12% 2.20% 6.51% 2.16% 2.39% -5.05% 7.81% 4.52% 5.12% 2.28% 4.17%
EBITDA Q/Q Growth		 1.61% 3.77% 29.06% -6.23% 9.36% -5.28% -15.09% -4.08% 28.86% 13.11% 8.97%
EBIT Q/Q Growth		 3.54% 4.42% 37.60% -8.43% 8.58% -3.74% -16.89% -4.99% 33.20% 14.65% 7.87%
NOPAT Q/Q Growth		 -7.62% -24.07% 36.50% -0.90% 7.44% 5.90% -27.67% -0.92% 25.11% 17.04% 6.05%
Net Income Q/Q Growth		 -3.14% 3.86% 37.60% 0.41% 7.36% 5.54% -27.79% -0.69% 25.83% 18.25% 5.25%
EPS Q/Q Growth		 0.00% 3.85% 36.84% 0.00% 9.52% 2.17% -25.00% -3.70% 28.57% 16.00% 7.59%
Operating Cash Flow Q/Q Growth		 -3.38% -17.31% -8.55% 8.21% 48.64% -3.10% -14.71% -185.11% 410.87% 62.58% -5.24%
Free Cash Flow Firm Q/Q Growth		 -5.41% -48.55% -59.39% 1,414.68% -2,620.25% 72.15% -28.64% -123.42% 58.93% 131.72% -13.73%
Invested Capital Q/Q Growth		 -3.49% 1.60% 6.31% -95.12% 6.15% 1.83% 0.53% 7.65% 2.47% -7.73% -2.72%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 70.07% 77.75% 79.53% 76.92% 76.19% 77.61% 76.36% 75.47% 75.98% 76.26% 78.08%
EBITDA Margin		 10.64% 16.81% 16.77% 12.40% 12.00% 18.04% 10.49% 8.64% 9.61% 13.56% 16.93%
Operating Margin		 6.75% 13.52% 13.80% 9.58% 9.04% 15.76% 8.78% 7.13% 8.34% 12.03% 15.09%
EBIT Margin		 6.75% 13.52% 13.80% 9.58% 9.04% 15.76% 8.78% 7.13% 8.34% 12.03% 15.09%
Profit (Net Income) Margin		 5.63% 9.62% 8.62% 6.47% 6.33% 12.81% 6.61% 5.53% 6.59% 9.41% 11.78%
Tax Burden Percent		 89.22% 72.72% 63.35% 67.02% 67.81% 79.42% 74.58% 76.91% 77.48% 73.20% 73.29%
Interest Burden Percent		 93.46% 97.85% 98.60% 100.73% 103.21% 102.36% 100.86% 100.84% 101.95% 106.91% 106.46%
Effective Tax Rate		 10.78% 27.28% 36.65% 32.98% 32.19% 20.58% 25.42% 23.09% 22.52% 26.81% 26.71%
Return on Invested Capital (ROIC)		 9.70% 18.84% 16.71% 23.68% 20.56% 21.50% 11.58% 9.80% 11.00% 16.37% 25.11%
ROIC Less NNEP Spread (ROIC-NNEP)		 15.70% 20.39% 17.46% 23.48% 19.82% 20.45% 11.40% 9.61% 10.22% 13.52% 22.20%
Return on Net Nonoperating Assets (RNNOA)		 -1.50% -4.23% -4.12% -10.87% -9.32% -6.64% -4.05% -2.88% -2.19% -3.84% -7.93%
Return on Equity (ROE)		 8.20% 14.61% 12.59% 12.81% 11.23% 14.87% 7.54% 6.92% 8.81% 12.53% 17.18%
Cash Return on Invested Capital (CROIC)		 17.50% 11.74% 0.35% 205.17% -164.22% 11.48% 7.98% -13.70% -4.30% 22.84% 27.04%
Operating Return on Assets (OROA)		 7.89% 16.37% 16.36% 16.96% 14.77% 16.34% 8.93% 7.57% 9.20% 13.43% 18.22%
Return on Assets (ROA)		 6.58% 11.65% 10.22% 11.45% 10.33% 13.28% 6.71% 5.87% 7.26% 10.51% 14.22%
Return on Common Equity (ROCE)		 8.20% 14.61% 12.59% 12.81% 11.23% 14.87% 7.54% 6.92% 8.81% 12.53% 17.18%
Return on Equity Simple (ROE_SIMPLE)		 7.85% 13.53% 11.69% 19.23% 7.70% 13.76% 7.29% 6.75% 8.41% 11.56% 0.00%
Net Operating Profit after Tax (NOPAT)		 1.17 2.26 2.26 1.82 1.92 4.06 2.34 2.29 3.11 4.82 7.08
NOPAT Margin		 6.02% 9.83% 8.74% 6.42% 6.13% 12.52% 6.55% 5.49% 6.46% 8.80% 11.06%
Net Nonoperating Expense Percent (NNEP)		 -5.99% -1.55% -0.76% 0.20% 0.74% 1.06% 0.18% 0.19% 0.79% 2.85% 2.92%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - 16.38%
Cost of Revenue to Revenue		 29.93% 22.25% 20.47% 23.08% 23.81% 22.39% 23.64% 24.53% 24.02% 23.74% 21.92%
SG&A Expenses to Revenue		 61.70% 62.57% 63.42% 66.45% 65.29% 61.42% 62.77% 65.09% 65.73% 63.03% 61.43%
R&D to Revenue		 1.63% 1.65% 2.31% 0.89% 1.86% 3.23% 4.82% 3.26% 1.91% 1.20% 1.56%
Operating Expenses to Revenue		 63.32% 64.23% 65.73% 67.34% 67.15% 61.85% 67.58% 68.34% 67.64% 64.23% 62.99%
Earnings before Interest and Taxes (EBIT)		 1.31 3.11 3.57 2.71 2.83 5.12 3.14 2.97 4.01 6.58 9.66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.07 3.87 4.34 3.51 3.76 5.86 3.75 3.60 4.62 7.42 11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.08 1.93 2.39 4.72 1.78 4.32 3.01 2.40 2.43 2.92 4.27
Price to Tangible Book Value (P/TBV)		 1.16 2.04 2.48 5.06 1.82 4.40 3.07 2.44 2.47 2.96 4.30
Price to Revenue (P/Rev)		 0.78 1.37 1.76 1.59 1.46 4.02 2.73 1.97 1.91 2.38 2.88
Price to Earnings (P/E)		 13.77 14.28 20.41 24.53 23.14 31.38 41.29 35.60 28.96 25.26 24.47
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 7.26% 7.00% 4.90% 4.08% 4.32% 3.19% 2.42% 2.81% 3.45% 3.96% 4.09%
Enterprise Value to Invested Capital (EV/IC)		 1.10 2.23 2.81 52.81 2.12 6.05 4.16 2.84 2.78 4.00 6.06
Enterprise Value to Revenue (EV/Rev)		 0.65 1.20 1.59 1.33 1.22 3.70 2.40 1.78 1.76 2.08 2.64
Enterprise Value to EBITDA (EV/EBITDA)		 6.15 7.16 9.47 10.69 10.13 20.51 22.85 20.54 18.27 15.36 15.61
Enterprise Value to EBIT (EV/EBIT)		 9.69 8.90 11.51 13.83 13.45 23.48 27.29 24.88 21.06 17.33 17.51
Enterprise Value to NOPAT (EV/NOPAT)		 10.86 12.24 18.17 20.64 19.83 29.56 36.59 32.35 27.18 23.67 23.89
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.57 12.77 34.49 15.36 14.69 28.64 27.85 0.00 64.19 12.58 14.84
Enterprise Value to Free Cash Flow (EV/FCFF)		 6.02 19.63 867.96 2.38 0.00 55.40 53.12 0.00 0.00 16.97 22.19
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.09 0.07 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.09 0.07 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.10 -0.21 -0.24 -0.46 -0.47 -0.32 -0.35 -0.30 -0.21 -0.28 -0.36
Leverage Ratio		 1.25 1.25 1.23 1.12 1.09 1.12 1.12 1.18 1.21 1.19 1.21
Compound Leverage Factor		 1.16 1.23 1.21 1.13 1.12 1.15 1.13 1.19 1.24 1.28 1.29
Debt to Total Capital		 8.25% 6.80% 5.68% 0.47% 0.12% 0.27% 0.17% 0.12% 0.23% 0.03% 0.00%
Short-Term Debt to Total Capital		 0.32% 0.26% 0.25% 0.32% 0.12% 0.24% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 7.92% 6.53% 5.43% 0.15% 0.00% 0.03% 0.17% 0.12% 0.23% 0.03% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 91.75% 93.20% 94.32% 99.53% 99.88% 99.73% 99.83% 99.88% 99.77% 99.97% 100.00%
Debt to EBITDA		 0.61 0.31 0.26 0.01 0.01 0.01 0.01 0.01 0.02 0.00 0.00
Net Debt to EBITDA		 -1.14 -1.02 -1.02 -2.11 -2.07 -1.77 -3.16 -2.25 -1.58 -2.16 0.00
Long-Term Debt to EBITDA		 0.58 0.30 0.25 0.00 0.00 0.00 0.01 0.01 0.02 0.00 0.00
Debt to NOPAT		 1.07 0.53 0.51 0.02 0.02 0.02 0.02 0.02 0.03 0.00 0.00
Net Debt to NOPAT		 -2.01 -1.74 -1.96 -4.08 -4.05 -2.56 -5.05 -3.55 -2.35 -3.34 0.00
Long-Term Debt to NOPAT		 1.03 0.51 0.49 0.01 0.00 0.00 0.02 0.02 0.03 0.00 0.00
Altman Z-Score		 4.71 7.04 9.58 40.15 10.19 29.12 15.15 9.42 9.45 13.09 13.55
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.52 5.15 6.38 10.42 6.72 9.38 6.83 4.83 4.69 5.75 4.31
Quick Ratio		 4.44 4.14 5.36 9.43 5.63 7.84 6.23 4.08 3.91 5.13 3.82
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 2.11 1.41 0.05 16 -15 2.17 1.61 -3.19 -1.21 6.72 7.62
Operating Cash Flow to CapEx		 531.59% 405.07% 192.50% 464.10% 194.90% 497.16% 1,072.13% -48.14% 79.79% 3,159.23% 4,348.47%
Free Cash Flow to Firm to Interest Expense		 24.59 21.10 0.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 32.45 32.44 23.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 26.35 24.43 11.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.17 1.21 1.19 1.77 1.63 1.04 1.02 1.06 1.10 1.12 1.21
Accounts Receivable Turnover		 2.98 3.25 2.95 0.00 0.00 2.53 2.39 2.19 2.13 2.31 2.67
Inventory Turnover		 2.70 2.25 2.10 0.00 0.00 2.55 3.25 3.86 3.12 3.27 4.00
Fixed Asset Turnover		 5.13 6.56 7.74 0.00 0.00 8.78 9.67 10.19 9.39 10.10 12.96
Accounts Payable Turnover		 12.64 9.07 8.45 0.00 0.00 12.73 13.62 10.50 8.77 10.91 7.63
Days Sales Outstanding (DSO)		 122.30 112.16 123.93 0.00 0.00 144.45 152.98 166.84 171.55 158.31 136.86
Days Inventory Outstanding (DIO)		 135.35 162.41 173.78 0.00 0.00 143.24 112.27 94.53 116.93 111.45 91.20
Days Payable Outstanding (DPO)		 28.88 40.23 43.19 0.00 0.00 28.68 26.80 34.76 41.61 33.47 47.83
Cash Conversion Cycle (CCC)		 228.77 234.34 254.52 0.00 0.00 259.02 238.46 226.61 246.87 236.30 180.23
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12 12 15 0.71 18 20 21 26 30 28 28
Invested Capital Turnover		 1.61 1.92 1.91 3.69 3.35 1.72 1.77 1.79 1.70 1.86 2.27
Increase / (Decrease) in Invested Capital		 -0.94 0.85 2.21 -14 17 1.90 0.73 5.48 4.32 -1.90 -0.54
Enterprise Value (EV)		 13 28 41 38 38 120 86 74 84 114 169
Market Capitalization		 15 32 46 45 46 131 98 82 92 130 184
Book Value per Share		 $1.71 $2.00 $2.32 $1.15 $3.06 $3.57 $3.75 $4.01 $4.40 $5.15 $5.15
Tangible Book Value per Share		 $1.59 $1.89 $2.23 $1.07 $2.99 $3.50 $3.68 $3.94 $4.33 $5.07 $5.11
Total Capital		 15 18 20 9.57 26 30 32 34 38 45 43
Total Debt		 1.25 1.19 1.15 0.05 0.03 0.08 0.05 0.04 0.09 0.01 0.00
Total Long-Term Debt		 1.20 1.15 1.10 0.01 0.00 0.01 0.05 0.04 0.09 0.01 0.00
Net Debt		 -2.35 -3.93 -4.43 -7.41 -7.78 -10 -12 -8.11 -7.29 -16 -15
Capital Expenditures (CapEx)		 0.52 0.53 0.62 0.53 1.33 0.84 0.29 1.43 1.65 0.29 0.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 6.76 7.68 10 0.02 13 15 15 19 22 20 19
Debt-free Net Working Capital (DFNWC)		 10 13 16 7.47 21 25 27 27 30 36 35
Net Working Capital (NWC)		 10 13 16 7.44 21 25 27 27 30 36 35
Net Nonoperating Expense (NNE)		 0.08 0.05 0.03 -0.01 -0.06 -0.10 -0.02 -0.02 -0.06 -0.33 -0.46
Net Nonoperating Obligations (NNO)		 -2.35 -3.93 -4.43 -8.81 -7.78 -10 -12 -8.11 -7.29 -16 -15
Total Depreciation and Amortization (D&A)		 0.76 0.76 0.77 0.80 0.93 0.74 0.61 0.63 0.61 0.84 1.17
Debt-free, Cash-free Net Working Capital to Revenue		 34.82% 33.39% 38.89% 0.06% 41.89% 45.06% 42.44% 46.17% 46.52% 37.31% 30.20%
Debt-free Net Working Capital to Revenue		 53.36% 55.68% 60.44% 26.40% 66.83% 77.33% 75.69% 65.75% 61.86% 66.70% 54.08%
Net Working Capital to Revenue		 53.11% 55.48% 60.25% 26.29% 66.74% 77.11% 75.69% 65.75% 61.86% 66.70% 54.08%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.13 $0.27 $0.27 $0.23 $0.24 $0.50 $0.28 $0.27 $0.37 $0.60 $0.89
Adjusted Weighted Average Basic Shares Outstanding		 8.12M 8.14M 8.17M 8.21M 8.31M 8.40M 8.57M 8.47M 8.46M 8.56M 8.45M
Adjusted Diluted Earnings per Share		 $0.13 $0.27 $0.26 $0.22 $0.23 $0.47 $0.27 $0.26 $0.36 $0.58 $0.85
Adjusted Weighted Average Diluted Shares Outstanding		 8.15M 8.25M 8.46M 8.62M 8.63M 8.83M 8.91M 8.77M 8.70M 8.86M 8.91M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.16M 8.22M 8.26M 8.33M 8.44M 8.57M 8.59M 8.48M 8.56M 8.64M 8.35M
Normalized Net Operating Profit after Tax (NOPAT)		 1.17 2.26 2.26 1.82 1.92 4.06 2.34 2.29 3.11 4.82 7.08
Normalized NOPAT Margin		 6.02% 9.83% 8.74% 6.42% 6.13% 12.52% 6.55% 5.49% 6.46% 8.80% 11.06%
Pre Tax Income Margin		 6.31% 13.23% 13.61% 9.65% 9.33% 16.13% 8.86% 7.19% 8.50% 12.86% 16.07%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 15.29 46.54 71.58 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 13.64 33.85 45.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 9.18 38.53 59.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 7.53 25.84 32.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 47.59% 62.82% 4.83% 5.34% 132.68%

Quarterly Metrics And Ratios for Electromed

This table displays calculated financial ratios and metrics derived from Electromed's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 8,555,238.00 8,581,677.00 8,605,227.00 - - - 8,556,844.00 8,386,115.00 8,349,176.00 8,340,538.00 8,275,313.00
DEI Adjusted Shares Outstanding		 8,555,238.00 8,581,677.00 8,605,227.00 - - - 8,556,844.00 8,386,115.00 8,349,176.00 8,340,538.00 8,275,313.00
DEI Earnings Per Adjusted Shares Outstanding		 0.02 0.20 0.17 - - - 0.22 0.26 0.26 0.33 0.36
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 15.63% 16.71% 14.94% 8.96% 19.02% 18.75% 13.07% 17.27% 15.13% 16.25% 18.43%
EBITDA Growth		 79.80% 71.79% 57.74% 51.04% 506.18% 13.84% 18.25% 35.05% 35.73% 37.81% 67.27%
EBIT Growth		 222.73% 77.63% 53.93% 56.29% 1,264.79% 12.33% 16.24% 30.19% 37.77% 42.41% 75.98%
NOPAT Growth		 35.36% 65.27% 33.22% 70.02% 1,232.55% 15.64% 26.52% 23.45% 51.87% 44.34% 64.96%
Net Income Growth		 91.36% 71.34% 38.88% 76.96% 850.97% 17.56% 26.66% 20.57% 44.91% 40.29% 58.80%
EPS Growth		 100.00% 72.73% 41.67% 66.67% 700.00% 15.79% 23.53% 30.00% 56.25% 45.45% 66.67%
Operating Cash Flow Growth		 85.60% 154.47% 109.13% 349.35% 1,046.31% -9.22% 53.52% -14.03% -92.68% -3.97% 67.60%
Free Cash Flow Firm Growth		 -210.29% -196.28% 104.25% 209.02% 115.96% 115.67% 2,007.46% -26.81% -119.43% -135.92% -114.08%
Invested Capital Growth		 0.00% 0.00% 4.10% -6.27% -11.62% -8.63% -7.00% -1.91% 10.86% 15.62% 12.12%
Revenue Q/Q Growth		 -9.46% 11.08% 1.33% 6.93% -1.11% 10.82% -3.51% 10.90% -2.91% 11.90% -1.70%
EBITDA Q/Q Growth		 -78.87% 594.38% -17.11% 24.21% -15.21% 30.40% -13.89% 41.85% -14.78% 32.40% 4.51%
EBIT Q/Q Growth		 -90.50% 1,493.66% -18.65% 26.83% -17.00% 31.17% -15.81% 42.06% -12.17% 35.58% 4.03%
NOPAT Q/Q Growth		 -90.00% 1,497.85% -12.72% 21.96% -21.65% 38.66% -4.50% 19.00% -3.62% 31.78% 9.14%
Net Income Q/Q Growth		 -85.00% 980.00% -10.81% 22.44% -19.37% 33.51% -3.91% 16.55% -3.09% 29.26% 8.76%
EPS Q/Q Growth		 -83.33% 850.00% -10.53% 17.65% -20.00% 37.50% -4.55% 23.81% -3.85% 28.00% 9.38%
Operating Cash Flow Q/Q Growth		 -124.42% 1,522.54% -61.08% 232.27% -48.56% 36.47% -34.18% 86.07% -95.62% 1,690.53% 14.87%
Free Cash Flow Firm Q/Q Growth		 -840.25% 9.03% 100.66% 1,836.04% 37.63% -10.68% -11.45% -32.54% -136.41% -65.17% 65.30%
Invested Capital Q/Q Growth		 2.91% -4.19% 3.02% -7.73% -2.97% -0.94% 4.86% -2.72% 9.71% 3.32% 1.69%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 77.07% 77.03% 74.85% 76.19% 78.34% 77.68% 77.97% 78.33% 78.15% 78.42% 78.83%
EBITDA Margin		 2.89% 18.06% 14.77% 17.16% 14.71% 17.31% 15.45% 19.76% 17.34% 20.52% 21.82%
Operating Margin		 1.15% 16.53% 13.27% 15.74% 13.21% 15.64% 13.64% 17.48% 15.81% 19.16% 20.27%
EBIT Margin		 1.15% 16.53% 13.27% 15.74% 13.21% 15.64% 13.64% 17.48% 15.81% 19.16% 20.27%
Profit (Net Income) Margin		 1.26% 12.23% 10.76% 12.32% 10.05% 12.11% 12.06% 12.67% 12.65% 14.61% 16.17%
Tax Burden Percent		 70.78% 70.96% 76.13% 73.21% 69.10% 73.05% 82.87% 69.42% 76.18% 74.04% 77.68%
Interest Burden Percent		 154.23% 104.24% 106.52% 106.94% 110.06% 105.98% 106.64% 104.44% 105.02% 103.01% 102.66%
Effective Tax Rate		 29.22% 29.04% 23.87% 26.79% 30.90% 26.95% 17.13% 30.58% 23.82% 25.96% 22.32%
Return on Invested Capital (ROIC)		 2.59% 40.49% 17.87% 21.43% 17.69% 23.76% 23.32% 27.54% 27.38% 33.10% 37.12%
ROIC Less NNEP Spread (ROIC-NNEP)		 1.03% 39.17% 16.88% 20.41% 16.40% 22.93% 22.45% 26.94% 26.65% 32.56% 36.64%
Return on Net Nonoperating Assets (RNNOA)		 -0.19% -10.08% -3.94% -5.80% -4.28% -7.27% -6.99% -9.63% -8.64% -10.98% -12.68%
Return on Equity (ROE)		 2.41% 30.40% 13.93% 15.63% 13.41% 16.49% 16.34% 17.91% 18.73% 22.12% 24.44%
Cash Return on Invested Capital (CROIC)		 -180.01% -174.90% 9.59% 22.84% 32.90% 31.01% 29.67% 27.04% 16.40% 14.66% 20.59%
Operating Return on Assets (OROA)		 1.30% 18.20% 15.48% 17.57% 16.22% 18.79% 16.54% 21.10% 20.42% 24.61% 25.99%
Return on Assets (ROA)		 1.42% 13.46% 12.55% 13.76% 12.33% 14.55% 14.62% 15.30% 16.34% 18.77% 20.73%
Return on Common Equity (ROCE)		 2.41% 30.40% 13.93% 15.63% 13.41% 16.49% 16.34% 17.91% 18.73% 22.12% 24.44%
Return on Equity Simple (ROE_SIMPLE)		 8.48% 9.76% 10.24% 0.00% 15.59% 15.51% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 0.10 1.61 1.40 1.71 1.34 1.86 1.77 2.11 2.03 2.68 2.93
NOPAT Margin		 0.82% 11.73% 10.10% 11.53% 9.13% 11.42% 11.31% 12.13% 12.04% 14.18% 15.75%
Net Nonoperating Expense Percent (NNEP)		 1.57% 1.31% 0.99% 1.02% 1.30% 0.83% 0.87% 0.60% 0.73% 0.54% 0.48%
Return On Investment Capital (ROIC_SIMPLE)		 - 3.98% 3.29% - - 4.26% 4.04% 4.88% 4.55% 5.90% 5.95%
Cost of Revenue to Revenue		 22.93% 22.97% 25.15% 23.81% 21.66% 22.32% 22.03% 21.67% 21.85% 21.58% 21.17%
SG&A Expenses to Revenue		 74.25% 59.72% 60.37% 59.26% 64.00% 60.50% 62.56% 59.12% 60.91% 57.23% 56.61%
R&D to Revenue		 1.67% 0.78% 1.20% 1.19% 1.13% 1.54% 1.77% 1.74% 1.43% 2.03% 1.94%
Operating Expenses to Revenue		 75.92% 60.50% 61.57% 60.45% 65.13% 62.04% 64.33% 60.85% 62.34% 59.26% 58.56%
Earnings before Interest and Taxes (EBIT)		 0.14 2.26 1.84 2.34 1.94 2.54 2.14 3.04 2.67 3.62 3.77
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 0.36 2.47 2.05 2.55 2.16 2.81 2.42 3.44 2.93 3.88 4.05
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.33 2.32 3.27 2.92 4.47 5.73 4.65 4.27 4.58 5.35 3.94
Price to Tangible Book Value (P/TBV)		 2.36 2.36 3.32 2.96 4.54 5.81 4.71 4.30 4.62 5.39 3.97
Price to Revenue (P/Rev)		 1.79 1.81 2.60 2.38 3.25 4.19 3.32 2.88 3.10 3.53 2.70
Price to Earnings (P/E)		 27.43 23.78 31.91 25.26 28.67 36.96 28.51 24.47 25.00 27.01 19.17
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.65% 4.21% 3.13% 3.96% 3.49% 2.71% 3.51% 4.09% 4.00% 3.70% 5.22%
Enterprise Value to Invested Capital (EV/IC)		 2.62 2.78 4.12 4.00 6.21 8.54 6.58 6.06 6.23 7.24 5.49
Enterprise Value to Revenue (EV/Rev)		 1.65 1.61 2.38 2.08 3.01 3.92 3.08 2.64 2.88 3.33 2.46
Enterprise Value to EBITDA (EV/EBITDA)		 17.14 14.32 19.40 15.36 18.61 24.43 19.01 15.61 16.45 18.09 12.36
Enterprise Value to EBIT (EV/EBIT)		 19.95 16.34 22.18 17.33 20.49 27.00 21.10 17.51 18.37 19.97 13.50
Enterprise Value to NOPAT (EV/NOPAT)		 26.22 22.14 30.93 23.67 28.34 37.07 28.30 23.89 24.54 26.63 18.13
Enterprise Value to Operating Cash Flow (EV/OCF)		 29.63 17.09 22.82 12.58 14.77 20.68 15.71 14.84 20.63 25.10 16.78
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 43.89 16.97 17.71 26.29 21.38 22.19 39.95 52.96 28.19
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.18 -0.26 -0.23 -0.28 -0.26 -0.32 -0.31 -0.36 -0.32 -0.34 -0.35
Leverage Ratio		 1.15 1.16 1.16 1.19 1.17 1.18 1.17 1.21 1.19 1.20 1.20
Compound Leverage Factor		 1.78 1.21 1.24 1.28 1.28 1.25 1.25 1.26 1.25 1.24 1.23
Debt to Total Capital		 0.18% 0.12% 0.07% 0.03% 0.02% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.18% 0.12% 0.07% 0.03% 0.02% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.82% 99.88% 99.93% 99.97% 99.98% 99.99% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 -1.46 -1.79 -1.78 -2.16 -1.50 -1.70 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 -2.23 -2.76 -2.84 -3.34 -2.29 -2.57 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 11.70 11.19 15.83 12.82 17.69 20.02 17.12 13.14 16.65 18.22 14.09
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 6.27 5.97 6.53 5.75 5.53 5.10 5.19 4.31 5.09 4.86 4.91
Quick Ratio		 5.28 5.08 5.63 5.13 4.88 4.50 4.54 3.82 4.44 4.27 4.42
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -31 -28 0.19 3.61 4.97 4.44 3.93 2.65 -0.97 -1.60 -0.55
Operating Cash Flow to CapEx		 -223.85% 4,888.73% 1,589.41% 20,404.55% 6,240.54% 1,352.36% 0.00% 2,661.38% 67.06% 477.29% 2,364.63%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.13 1.10 1.17 1.12 1.23 1.20 1.21 1.21 1.29 1.28 1.28
Accounts Receivable Turnover		 2.12 2.25 2.31 2.31 2.49 2.61 2.60 2.67 2.81 2.81 2.78
Inventory Turnover		 2.69 2.55 3.31 3.27 3.37 3.53 3.86 4.00 4.04 4.59 4.94
Fixed Asset Turnover		 8.99 9.61 9.92 10.10 10.83 11.26 12.17 12.96 13.27 13.20 14.32
Accounts Payable Turnover		 11.40 11.67 12.13 10.91 9.39 10.86 10.33 7.63 5.91 7.84 6.92
Days Sales Outstanding (DSO)		 172.14 162.32 157.79 158.31 146.55 140.07 140.65 136.86 129.87 129.96 131.48
Days Inventory Outstanding (DIO)		 135.74 143.07 110.32 111.45 108.26 103.51 94.56 91.20 90.42 79.60 73.89
Days Payable Outstanding (DPO)		 32.03 31.29 30.09 33.47 38.86 33.62 35.35 47.83 61.77 46.57 52.78
Cash Conversion Cycle (CCC)		 275.85 274.09 238.01 236.30 215.95 209.95 199.87 180.23 158.52 162.98 152.59
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 31 30 31 28 28 27 29 28 31 32 32
Invested Capital Turnover		 3.18 3.45 1.77 1.86 1.94 2.08 2.06 2.27 2.27 2.33 2.36
Increase / (Decrease) in Invested Capital		 31 30 1.22 -1.90 -3.63 -2.59 -2.16 -0.54 3.00 4.28 3.48
Enterprise Value (EV)		 82 83 127 114 172 234 189 169 191 229 177
Market Capitalization		 89 94 139 130 185 250 204 184 205 243 194
Book Value per Share		 $4.47 $4.70 $4.94 $5.15 $4.80 $5.16 $5.14 $5.15 $5.36 $5.45 $5.94
Tangible Book Value per Share		 $4.40 $4.63 $4.87 $5.07 $4.73 $5.08 $5.07 $5.11 $5.31 $5.40 $5.90
Total Capital		 38 40 43 45 41 44 44 43 45 45 49
Total Debt		 0.07 0.05 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.07 0.05 0.03 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -6.96 -10 -12 -16 -14 -16 -15 -15 -14 -14 -17
Capital Expenditures (CapEx)		 0.11 0.07 0.09 0.02 0.04 0.23 -0.15 0.15 0.25 0.63 0.15
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 23 22 23 20 20 19 20 19 22 22 23
Debt-free Net Working Capital (DFNWC)		 30 33 35 36 34 36 36 35 36 36 40
Net Working Capital (NWC)		 30 33 35 36 34 36 36 35 36 36 40
Net Nonoperating Expense (NNE)		 -0.05 -0.07 -0.09 -0.12 -0.13 -0.11 -0.12 -0.09 -0.10 -0.08 -0.08
Net Nonoperating Obligations (NNO)		 -6.96 -10 -12 -16 -14 -16 -15 -15 -14 -14 -17
Total Depreciation and Amortization (D&A)		 0.21 0.21 0.21 0.21 0.22 0.27 0.28 0.40 0.26 0.26 0.29
Debt-free, Cash-free Net Working Capital to Revenue		 47.04% 43.06% 43.52% 37.31% 34.57% 32.35% 33.28% 30.20% 32.75% 32.53% 32.08%
Debt-free Net Working Capital to Revenue		 61.16% 63.24% 65.42% 66.70% 58.87% 59.57% 58.08% 54.08% 54.06% 52.56% 55.75%
Net Working Capital to Revenue		 61.16% 63.24% 65.42% 66.70% 58.87% 59.57% 58.08% 54.08% 54.06% 52.56% 55.75%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.02 $0.20 $0.17 $0.21 $0.17 $0.23 $0.22 $0.27 $0.26 $0.33 $0.37
Adjusted Weighted Average Basic Shares Outstanding		 8.54M 8.55M 8.57M 8.56M 8.56M 8.42M 8.50M 8.45M 8.32M 8.27M 8.21M
Adjusted Diluted Earnings per Share		 $0.02 $0.19 $0.17 $0.20 $0.16 $0.22 $0.21 $0.26 $0.25 $0.32 $0.35
Adjusted Weighted Average Diluted Shares Outstanding		 8.78M 8.80M 8.89M 8.86M 8.98M 8.95M 8.97M 8.91M 8.68M 8.69M 8.65M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 8.58M 8.61M 8.66M 8.64M 8.46M 8.56M 8.39M 8.35M 8.34M 8.28M 8.28M
Normalized Net Operating Profit after Tax (NOPAT)		 0.10 1.61 1.40 1.71 1.34 1.86 1.77 2.11 2.03 2.68 2.93
Normalized NOPAT Margin		 0.82% 11.73% 10.10% 11.53% 9.13% 11.42% 11.31% 12.13% 12.04% 14.18% 15.75%
Pre Tax Income Margin		 1.78% 17.23% 14.14% 16.84% 14.54% 16.57% 14.55% 18.25% 16.60% 19.73% 20.81%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.25% 0.00% 0.00% 5.34% 74.37% 71.14% 92.25% 132.68% 78.88% 102.65% 75.09%

Financials Breakdown Chart

Electromed Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Electromed's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

Electromed's net income appears to be on an upward trend, with a most recent value of $7.54 million in 2025, rising from $1.09 million in 2015. The previous period was $5.15 million in 2024. View Electromed's forecast to see where analysts expect Electromed to go next.

Electromed's total operating income in 2025 was $9.66 million, based on the following breakdown:
  • Total Gross Profit: $49.97 million
  • Total Operating Expenses: $40.31 million

Over the last 10 years, Electromed's total revenue changed from $19.41 million in 2015 to $64 million in 2025, a change of 229.8%.

Electromed's total liabilities were at $10.59 million at the end of 2025, a 37.8% increase from 2024, and a 204.2% increase since 2015.

In the past 10 years, Electromed's cash and equivalents has ranged from $3.60 million in 2015 to $16.08 million in 2024, and is currently $15.29 million as of their latest financial filing in 2025.

Over the last 10 years, Electromed's book value per share changed from 1.71 in 2015 to 5.15 in 2025, a change of 201.0%.


Related Companies

Financial statements for NYSE:ELMD last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Simple Options Trading For Beginners' book at no cost - normally $29.97. It ou...
Profits Run | Sponsoredtc pixel
The Starlink of Energy
A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...
Monument Traders Alliance | Sponsoredtc pixel
The tiny chipmaker set to supply Musk 5 billion chips
SpaceX and xAI just completed a $1.25 trillion merger - and Musk may no longer need data centers from Microsof...
Brownstone Research | Sponsoredtc pixel
The market’s crashing? … There’s an app for that
During the Great Financial Crisis, one firm accurately predicted 464 of 465 bank failures before they happened...
Weiss Ratings | Sponsoredtc pixel